Search - tctmd.com

Displaying 481 - 500 of 1561

Sort: Relevancy | Date

Presentation TVT 2021

Non-Implant Transeptal LAA Occlusion by Invagination (Append Medical)

Presenter: Horst Sievert

July 22, 2021

Presentation TVT 2021

Are We Truly Prime Time for ICE or Only in Patients Suboptimal for TEE?

Presenter: Miguel Valderrábano

July 22, 2021

Presentation TVT 2021

How Has the Watchman FLX Improved Outcomes vs Watchman 2.5?

Presenter: Brijeshwar Maini

July 22, 2021

Presentation TVT 2021

Three Cases of Challenging Anatomy for Left Atrial Appendage Closure

Presenter: Sameer Gafoor

July 22, 2021

Presentation TVT 2021

Using Imaging Guidance for Optimal TS Location and Guide Catheter Shape

Presenter: Matthew Price

July 22, 2021

Presentation TVT 2021

High Success and Low Complications of LAAO: Should All AF Patients Having Transcatheter Procedures Be Offered LAAO?

Presenter: Saibal Kar

July 22, 2021

Presentation TVT 2021

What Are the New LAAO Devices and What Problems Are They Solving

Presenter: Megan Coylewright

July 22, 2021

Presentation TVT 2021

How to Create an LAAO Program: From Physician Competency to Patient Education

Presenter: Shephal Doshi

July 22, 2021

Presentation TVT 2021

Clinical Data Refresh: What's New in LAAO

Presenter: Vivek Reddy

July 22, 2021

Presentation TVT 2021

Next Generation Stroke Reduction

Presenter: Wayne Batchelor

July 21, 2021

Presentation TVT 2021

Case Conclusion

Presenter: Thomas Waggoner

July 21, 2021

Presentation TVT 2021

Post-Procedure Management

Presenter: Robert Sommer

July 21, 2021

Presentation TVT 2021

Pre-Procedural and Implant Guidance

Presenter: Megan Coylewright

July 21, 2021

Presentation TVT 2021

WATCHMAN FLX: CHAMPION-AF Case Study

Presenter: Thomas Waggoner

July 21, 2021

News Industry News

BIOMODEX Technology Enables New Milestone in Interventional Cardiology

July 21, 2021

Presentation TVT 2021

Transfemoral Transcatheter Tricuspid Valve Replacement With the EVOQUE System for Severe Tricuspid Regurgitation: A Multicenter, First-in-Human 1-Year Observation

Presenter: Ming-yu (Anthony) Chuang

July 21, 2021

Presentation TVT 2021

First Commercial Multicenter Experience With the PASCAL Transcatheter Valve Repair System for Tricuspid Regurgitation

Presenter: Jörg Hausleiter

July 21, 2021

Presentation TVT 2021

First Report of 2-Year Outcomes With a Next-Generation Left Atrial Appendage Closure Device: Final Results From the PINNACLE FLX IDE Trial

Presenter: Saibal Kar

July 21, 2021

News Daily News

Predictors of Device-Related Thrombus Following LAA Occlusion

Shelley Wood

July 19, 2021

News Conference News ACC 2021

Low 1-Year Stroke Risk After Commercial Watchman Use

Todd Neale

May 15, 2021

Advertisement

Non-Implant Transeptal LAA Occlusion by Invagination (Append Medical)

Are We Truly Prime Time for ICE or Only in Patients Suboptimal for TEE?

How Has the Watchman FLX Improved Outcomes vs Watchman 2.5?

Three Cases of Challenging Anatomy for Left Atrial Appendage Closure

Using Imaging Guidance for Optimal TS Location and Guide Catheter Shape

High Success and Low Complications of LAAO: Should All AF Patients Having Transcatheter Procedures Be Offered LAAO?

What Are the New LAAO Devices and What Problems Are They Solving

How to Create an LAAO Program: From Physician Competency to Patient Education

Clinical Data Refresh: What's New in LAAO

Next Generation Stroke Reduction

Case Conclusion

Post-Procedure Management

Pre-Procedural and Implant Guidance

WATCHMAN FLX: CHAMPION-AF Case Study

BIOMODEX Technology Enables New Milestone in Interventional Cardiology

Transfemoral Transcatheter Tricuspid Valve Replacement With the EVOQUE System for Severe Tricuspid Regurgitation: A Multicenter, First-in-Human 1-Year Observation

First Commercial Multicenter Experience With the PASCAL Transcatheter Valve Repair System for Tricuspid Regurgitation

First Report of 2-Year Outcomes With a Next-Generation Left Atrial Appendage Closure Device: Final Results From the PINNACLE FLX IDE Trial

Predictors of Device-Related Thrombus Following LAA Occlusion

Low 1-Year Stroke Risk After Commercial Watchman Use

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content